BENTSUR RON Insider Trading Activity

Average Profitability
27.08%
Insider Buys Quantity
58
Insider Buys Sum
$3.58M
Insider Sells Quantity
26
Insider Sells Sum
$1.51M

Insider Activity of BENTSUR RON

According to the SEC Form 4 filings, BENTSUR RON, being in a position of

  1. Chairman & CEO at Nuvectis Pharma, Inc.,
    оver the last 12 months, has bought 17500 shares for $278,600, and sold 0 shares,
    over all time since 2022-02-04, has bought 627675 shares for $3.82M, and sold 0 shares.

Biography of BENTSUR RON

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $278,6002100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-06-30PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
12,500
0.0513%
$20.00$250,000+9.52%
2025-11-05PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
5,000
0.0167%
$5.72$28,600+68.85%
2024-12-24PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
4,500
0.0233%
$4.65$20,925+48.71%
2024-11-15PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
20,000
0.0887%
$4.92$98,400+35.96%
2024-05-14PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,940
0.0105%
$6.74$13,076-1.85%
2024-05-10PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
2,000
0.0109%
$6.40$12,800+3.59%
2024-03-18PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
5,000
0.0283%
$10.29$51,450-37.18%
2023-10-10PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
640
0.0038%
$11.08$7,091-33.95%
2023-10-09PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
830
0.0049%
$11.19$9,288-34.72%
2023-10-06PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
250
0.0014%
$11.27$2,818-36.77%
2023-10-05PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,400
0.0076%
$11.09$15,526-34.22%
2023-10-04PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
1,820
0.0098%
$10.95$19,929-34.82%
2023-08-16PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
115
0.0008%
$15.15$1,742-43.03%
2023-08-15PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
235
0.0015%
$14.34$3,370-42.41%
2023-08-11PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
180
0.0011%
$14.66$2,639-46.47%
2023-08-08PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
120
0.0008%
$14.83$1,780-44.59%
2023-07-21PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
225
0.0015%
$14.85$3,341-44.81%
2023-07-20PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
110
0.0008%
$15.06$1,657-41.95%
2023-07-19PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
200
0.0013%
$14.33$2,866-42.75%
2023-07-14PurchaseNuvectis Pharma, Inc.
NVCT
Chairman & CEO
150
0.001%
$15.03$2,255-44.26%
Total: 86
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.